细菌响应性药物输送系统利用碳氧甲基纤维素功能化的金属有机框架,提高抗菌效率
Pingping Yuan1,2, Mengying Zhang1, Sheng Wang1
1Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University, Hefei 230036, China.
ACS biomaterials science & engineering
|March 25, 2025
概括
使用金属有机框架 (MOF) 的新型智能药物输送系统有效打击抗生素耐药性. 这种对细菌敏感的系统增强了ceftiofur的释放,清除了Pseudomonas aeruginosa,并改善了小鼠的伤口愈合.
科学领域:
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗生素耐药性是一个日益严重的全球健康危机.
- 过度使用抗生素加速了耐药细菌菌株的发展.
- 创新的药物输送系统对于克服抗生素耐药性至关重要.
研究的目的:
- 使用金属有机框架 (MOFs) 开发一种对细菌有反应的药物输送系统.
- 为了增强ceftiofur (EFT) 对细菌感染的疗效.
- 研究基于MOF的系统在打击抗生素耐药性的潜力.
主要方法:
- 酸伊米达框架8 (ZIF-8) 被用作塞夫提奥弗 (EFT) 的载体.
- 开发了一个智能药物输送系统 (CMC-EFT@ZIF-8),增强了碳甲基纤维素.
- 对EFT释放的系统对pH和细胞酶的响应性进行了评估.
- 在实验室对Pseudomonas aeruginosa的疗效和在小鼠皮肤伤口模型中的体内疗效进行了评估.
主要成果:
- CMC-EFT@ZIF-8系统在酸性条件下和在细胞酶的存在下显示出增强的EFT释放.
- 该系统有效地破坏了细菌膜,导致细菌死亡.
- 在体外6小时内,Pseudomonas aeruginosa的清除率达到了99%.
- 在小鼠皮肤伤口模型中观察到更高的疗效.
结论:
- 开发的智能药物输送系统显示了治疗细菌感染的巨大潜力.
- 这种基于MOF的系统代表了打击抗生素耐药性的进步.
- 该系统对细菌的反应性质提高了治疗结果.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...